Use of ferric citrate having a dissolution rate of at least approximately 2mg/cm2/min in the manufacture of a medicament for treating soft tissue calcification and pharmaceutical compositions comprising same ferric citrate

摘要

The present invention discloses pharmaceutical-grade ferric organic compounds having enhanced dissolution rate. These ferric organic compounds, including but are not limited to ferric citrate, are useful for treating chronic kidney disease.